logo
Share SHARE
FONT-SIZE Plus   Neg

Oshkosh Q2 Profit Down - Quick Facts

Oshkosh Corp. (OSK) reported second quarter net income attributable to the company of $37.3 million, or $0.41 per share, compared to $67.9 million, or $0.74 per share, in the second quarter of fiscal 2011.

Results for the second quarter of fiscal 2012 included after-tax charges of $0.02 per share related to the proxy contest in connection with the Company's 2012 annual shareholders' meeting and $0.02 per share related to the Company's exit from its U.S. mobile medical trailer product line and workforce reductions at Pierce.

Consolidated net sales in the second quarter of fiscal 2012 were $2.08 billion, an increase of 18.9 percent compared to the prior year second quarter.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.26 per share on revenues of $1.81 billion for the quarter. Analysts' estimates typically exclude special items.

The company increased its outlook for fiscal 2012 primarily due to stronger than expected orders and sales in the access equipment segment in the second quarter of fiscal 2012. The Company now expects sales in the access equipment segment will be 35 percent to 40 percent higher in fiscal 2012 compared to fiscal 2011 with operating income margins of 7.5 percent to 8.0 percent in the segment.

In addition, the company has reduced expectations for the fire & emergency segment's operating income to approximately breakeven as a result of second quarter results in this segment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Shares of Nokia Corp. were gaining around 6 percent in mid-morning trading in Finland after the network equipment maker reported Thursday narrower loss in its first quarter. The company also reiterated its fiscal 2017 outlook for total cost savings. CEO Rajeev Suri said, "Overall, given Nokia's performance in the first quarter, I am optimistic about the year ahead, even if cautiously so." Aerospace and defense major Airbus Group SE reported Thursday higher profit and revenues in its first quarter with growth in all segments, except defence. Adjusted EBIT, a key earnings metric, meanwhile declined from last year. Looking ahead, for fiscal 2017, Airbus continues to expect mid-single-digit percentage growth in adjusted earnings per share and adjusted EBIT. Shares of AstraZeneca Plc were declining in the morning trading in London after the British drug giant reported Thursday weak profit and revenues in its first quarter, as product sales were hurt mainly by the residual impact of the US Crestor patent expiry. Core profit, however, increased with improved cost control. Further, the company confirmed its financial guidance for 2017.
comments powered by Disqus
Follow RTT